Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis
BackgroundConcurrent chemoradiotherapy (CRT) is the preferred treatment strategy for inoperable esophageal cancer (EC). However, the effect of CRT needs to be improved.MethodsThis study comprehensively analyzed targeted agents combined with CRT for the treatment of EC by a network meta-analysis. The...
Guardado en:
Autores principales: | Peng Liu, Guo-Fei Wang, Hua Peng, Lei Zhang, Xiao-Yan Li, Qiao-Miao Zeng, Qian Li, Jian-Hui Zhou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2cfad9d116e243988f8da8f213c4f367 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update
por: Pollock AE, et al.
Publicado: (2018) -
The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Hao Lv, et al.
Publicado: (2021) -
Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Noriaki Ito, et al.
Publicado: (2021) -
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
por: Jaehyeon Park, et al.
Publicado: (2021) -
Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study
por: Chuangzhen Chen, et al.
Publicado: (2021)